Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Biomatrix's viscosupplementation product to be distributed by Bayer

May 2, 1997

Clodronate shows comparable efficacy to indomethacin in a rat model of arthritis

May 2, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

Genelabs reports preliminary results from phase III trial of GL-701 for lupus

April 28, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

Signal describes agents that block transcription factor activation

April 24, 1997

Phase III results for TS-110 in osteoarthritis

April 23, 1997

Caspase-1 involved in the regulation of multiple cytokines

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...